Alkhodier Alkhodier

Dr. Alkhodier Alkhodier


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2023 in Cureus
Verified
Journal Article
Open access
PDF file
AAAlkhodier Alkhodier
Alkhodier Alkhodier
AAAbdurhman S. Alsaif
Abdurhman S. Alsaif
NANorah H. Alqntash
Norah H. Alqntash
RARakan B. Alanazi
Rakan B. Alanazi
GAGhaida Alotaibi
Ghaida Alotaibi
AAAbeer A. Alkhodier
Abeer A. Alkhodier
Background Rheumatic diseases pose risks to pregnant women, leading to complications like preterm birth, congenital heart block, and pregnancy loss. These diseases are expected to deteriorate during pregnancy and further in the postpartum period. The impact of these diseases on the pregnancy will add further burden on the patient, fetus, physician, and healthcare system. Advances in diagnosis and treatment have improved outcomes making them similar to that of healthy women, but close follow-up in a multidisciplinary clinic is essential. The objective of this study is to study the outcome of pregnancy in women with rheumatological disease and the behavior of the disease during pregnancy. Methods A retrospective cohort study was conducted in King Abdulaziz Medical City (KAMC) in Riyadh, Saudi Arabia, to compare the outcomes of pregnancy across three rheumatological diseases: Sjogren syndrome (SS), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA) from 2016 to 2021. A total of 128 pregnancies in 107 women with rheumatological diseases were included in this study. Pregnancy measures and outcomes were investigated by assessing maternal health, fetal health, and pregnancy complications, specifically maternal disease activity, medications to control the disease, infection, preterm birth, birth weight, abortions/stillbirths, mode of delivery, bleeding, preeclampsia, congenital heart block, and neonatal lupus. Results There were 55 patients with RA (63 RA pregnancies), 44 with SLE (54 SLE pregnancies), and eight with primary SS (11 SS pregnancies). In most of the pregnancies (n= 108; 95.58%), the patients were in clinical remission before pregnancy. Lupus nephritis, which was in remission before pregnancy, has been reported in nine (16.67%) out of 54 SLE pregnancies. Vaginal delivery was the most common mode of delivery (n=87; 67.97%). On the other hand, there were 38 cesarean sections (29.69%). Rheumatological disease flares occurred in 10 pregnancies (7.87%). One hundred and twenty-two live births were delivered. Preterm infants were born in 25 pregnancies (20.16%), and 16 (13.22%) of the newborns needed neonatal intensive care unit (NICU) care. Interestingly, congenital heart block (CHB) was found in five (12.2%) neonates out of 41 anti-SS-related antigen A (anti-SSA) positive mothers; one of those five died from heart block. Eleven neonates were delivered with positive serology, and five were diagnosed with neonatal lupus. Conclusion The outcome of pregnancy in patients with rheumatological disease is favorable. A multidisciplinary team approach and close clinical follow-up are the cornerstone for such success. A small dose of prednisolone (5 mg or less) is safe and will not have a negative impact on maternal or fetal health. CHB is a concern for pregnant women with positive anti-SSA.

1 April 2025 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
RARana Alhumaemydi
Rana Alhumaemydi
AAAlkhodier Alkhodier
Alkhodier Alkhodier
IAIsmail Alghamdi
Ismail Alghamdi
Introduction: Botulinum toxin (Botox) can be used to manage strabismus due to its efficacy in inducing muscle paralysis by blocking acetylcholine release. Botox is an important treatment for many conditions in ophthalmology; however, clinicians must be aware of its potential complications, such as mydriasis. Mydriasis is defined as dilation in the pupils, and it can be divided into two subsets: transient and persistent mydriasis. Case presentation: This report presents a case of a 4-year-old child having esotropia (ET) with an angle of 30 Prism Dioptre (PD) and Inferior Oblique muscle Overaction (IOOA). The patient was scheduled for Botox injection to correct ET and IOOA and developed transient bilateral mydriasis. Discussion: Botox is a valuable therapeutic intervention in pediatric ophthalmology. A potential side effect of it is transient mydriasis, which developed in this patient. Interestingly, a higher dose of Botox injected a second time didn't result in mydriasis, which depicts a potential variability in patient responses to Botox. The mechanisms behind this adverse effect and its occurrence regardless of the dose remain unclear, but proposed hypotheses suggest that toxin diffusion could impact nearby structures, such as the ciliary ganglion or pupillary sphincter muscle, leading to pupil dilation. In addition, this case highlights the importance of vigilant post-injection monitoring. Further research and investigation are warranted to elucidate the possible underlying mechanisms in order to provide guidance for clinical practice. Conclusion: Collectively, our results confirm that the patient developed transient bilateral mydriasis as a result of Botox injection. Highlights:

1 May 2025 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
DBDania Bamefleh
Dania Bamefleh
KAKhaled Alabduljabbar
Khaled Alabduljabbar
AAAlkhodier Alkhodier
Alkhodier Alkhodier
Introduction: Managing intraocular pressure (IOP) in aphakic glaucoma is challenging, as it may often require glaucoma drainage devices (GDDs). While the Ahmed glaucoma valve (AGV) is widely used, the Paul glaucoma implant (PGI) is emerging as a viable alternative with potential advantages in IOP control and fewer complications. This report compares AGV and PGI outcomes in aphakic glaucoma management. Case presentation: A 15-year-old male with congenital cataracts and aphakic glaucoma presented with uncontrolled IOP despite medical therapy. The right eye underwent AGV surgery, while the left underwent PGI surgery. Both devices controlled IOP , though the AGV required repositioning due to tube migration, whereas the PGI resulted in a transient IOP rise before stabilizing. Discussion: Both the AGV and PGI effectively controlled IOP. The PGI provided more stable visual outcomes. While studies report similar IOP reductions for both devices, the PGI's design may contribute to more predictable visual stabilization. Tube migration, a complication observed with the AGV in this case, has been reported in other studies. The PGI may offer fewer complications and better long-term vision outcomes, making it a promising option for pediatric aphakic glaucoma management. Conclusion: In this pediatric aphakic glaucoma case, the PGI resulted in more stable visual outcomes compared to the AGV. While both implants were effective in IOP control, the PGI may offer better long-term stability with fewer complications. However, further studies involving larger cohorts are required to validate these findings. Highlights:

9 October 2026 in Medicine
Verified
Journal Article
Open access
MAMohammed M Abusayf
Mohammed M Abusayf
RARana Fahad Alhumaemydi
Rana Fahad Alhumaemydi
AAAlkhodier Alkhodier
Alkhodier Alkhodier
MAMajed Alkharashi
Majed Alkharashi
Rationale: Gelatinous drop-like corneal dystrophy (GDLD) is a rare autosomal recessive disorder characterized by subepithelial amyloid deposition, progressive corneal opacification, and recurrent erosions. GDLD may present during the first decade of life and interfere with visual development. It may recur after keratoplasty, complicating surgical management. Patient concerns: A 21-year-old woman of Yemeni ancestry, living in a remote area with limited access to corneal transplantation, presented with progressive left eye visual decline and foreign body sensation since early childhood. She had long-standing bilateral visual impairment and a positive family history. Her first surgery was right eye penetrating keratoplasty (PK), performed elsewhere approximately 1 year earlier for an undiagnosed opacity. Diagnoses: Examination revealed nystagmus, a clear right graft with yellowish recipient deposits, and dense limbus-to-limbus left corneal opacification with stromal haze, mulberry-like deposits, and neovascularization. Uncorrected visual acuity (VA) was 20/200 in the right eye and counting fingers in the left. Best spectacle-corrected VA was 20/100 in the right eye, while reliable refraction could not be obtained in the left. Histopathology demonstrated Congo red-positive subepithelial amyloid deposits with birefringence under polarized light, confirming GDLD. Genetic testing for tumor-associated calcium signal transducer 2 was not performed. Interventions: The left eye underwent superficial keratectomy and attempted lamellar dissection assisted by intraoperative optical coherence tomography; dense deep stromal opacity necessitated conversion to full-thickness PK. Outcomes: Both grafts remained clear without rejection during follow-up. Minimal focal subepithelial haze in a temporal area of the left donor graft was noted at the 2 most recent visits, remained stationary between them, and was clinically insignificant. At final follow-up, approximately 2 years after right eye PK and 10 months after left eye PK, best spectacle-corrected VA was 20/100 in the right eye and 20/80 − 1 in the left. Intraocular pressure was normal, and posterior pole examinations were unremarkable. Lessons: Advanced bilateral GDLD poses clinical and surgical challenges. PK may restore corneal clarity and provide meaningful visual rehabilitation, although recovery may remain incomplete after early-onset visual impairment and delayed treatment. Long-term monitoring is essential because recurrence and repeat intervention may be required. Early recognition, timely referral, and individualized management matter where donor corneal tissue access is limited.